High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$138K
$138,649
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
2026-03-26
$24,011x2
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
|
2026-03-26 | $24,011x2 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
2026-03-25
$17,885
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
|
2026-03-25 | $17,885 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to CoverΔOwn -14.0%
2025-11-18
$96,754
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to CoverΔOwn -14.0%
|
2025-11-18 | $96,754 | S | Form 4 |